Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick. - MedPage Today
The Stop-or-Not Trial found no significant difference in death and major complications at 28 days after noncardiac surgery between continuing and discontinuing renin-angiotensin system (RAS) inhibitor therapy, suggesting both strategies are acceptable. Clinicians should manage RAS inhibitor therapy based on individual patient factors and surgery specifics.
Highlighted Terms
Related News
Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick. - MedPage Today
The Stop-or-Not Trial found no significant difference in death and major complications at 28 days after noncardiac surgery between continuing and discontinuing renin-angiotensin system (RAS) inhibitor therapy, suggesting both strategies are acceptable. Clinicians should manage RAS inhibitor therapy based on individual patient factors and surgery specifics.